Pfizer has called a halt to a clinical trial of its gene therapy for Duchenne muscular dystrophy as it investigates ... when it acquired Bamboo Therapeutics in a deal worth up to $645 million.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...